Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva appeals to Supreme Court for help thwarting Copaxone rivals
Fierce Pharma
Thursday, January 23, 2014 - 7:50am
tags:
Copaxone, Teva Pharmaceuticals, patents, MS, Supreme Court, multiple sclerosis
Amarin Tumbles after DMEP Decision
Yahoo/Zacks.com
Wednesday, January 22, 2014 - 5:23pm
tags:
Amarin, DMEP, Vascepa
Regulators Ask: Is FDA's Generic Drug Submission Process Broken?
Regulatory Focus
Wednesday, January 22, 2014 - 5:22pm
tags:
FDA, generics
Stryker fourth quarter net profit rises 43 percent
Reuters
Wednesday, January 22, 2014 - 5:20pm
tags:
Stryker, devices, earnings
Narrower-than-Expected Loss at Ironwood, Shares Up
Yahoo/Zacks.com
Wednesday, January 22, 2014 - 5:19pm
tags:
earnings, Ironwood Pharmaceuticals
Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease
Seeking Alpha
Wednesday, January 22, 2014 - 5:16pm
tags:
Athersys, inflammatory bowel disease, MAPCs, Pfizer
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal
Yahoo/Zacks.com
Wednesday, January 22, 2014 - 4:14pm
tags:
Sarepta Therapeutics, Alnylam, Jazz Pharmaceuticals, Regeneron, Celgene
Why Investors Are Shrugging Off Amag Pharma's Feraheme FDA Rejection
TheStreet.com
Wednesday, January 22, 2014 - 3:50pm
tags:
Amag Pharmaceuticals, FDA, Feraheme
Nektar Momentum Continues To Grow
Seeking Alpha
Wednesday, January 22, 2014 - 3:46pm
tags:
Nektar, Naloxegol
Quest will buy Solstas Lab Partners for $570M
Yahoo/AP
Wednesday, January 22, 2014 - 11:10am
tags:
Quest Diagnostics, M&A, Solstas Lab Partners
NuVasive loses a bid to toss a patent infringement lawsuit filed by AngleFix over plate-and-screw spinal implant technology
Mass Device
Wednesday, January 22, 2014 - 10:48am
tags:
NuVasive, AngleFix, devices
EMA Bests FDA in 2013 New Drug Approval Numbers
Fierce Biotech
Wednesday, January 22, 2014 - 10:40am
tags:
EMA, FDA, drug approvals
Novartis to Shut New York Plant as Diovan Sales Decline
Bloomberg
Wednesday, January 22, 2014 - 10:24am
tags:
Novartis, drug manufacturing, Diovan
Q4 venture haul pushes 2013 biotech investing past $4.5B
Fierce Biotech
Wednesday, January 22, 2014 - 10:21am
tags:
biotech
What's a $2.9B deal + increasing sales equal? One enthused new CEO at Forest
Fierce Pharma
Wednesday, January 22, 2014 - 10:19am
tags:
Forest Labs, Pharma CEOs, Brent Saunders
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Yahoo/24-7 Wall St
Wednesday, January 22, 2014 - 8:41am
tags:
Teva Pharmaceuticals, M&A, Idenix, Insmed, NuPathe, InterMune, Puma Biotechnology
St. Jude forecasts 2014 growth in sales and revenue
Yahoo/Reuters
Wednesday, January 22, 2014 - 8:39am
tags:
St. Jude Medical, devices
Abbott revenue misses, hurt by dollar, weak formula sales
Yahoo/Reuters
Wednesday, January 22, 2014 - 8:38am
tags:
Abbott Laboratories, earnings
Torrent Pharma surges; margins driven profit impress street
Yahoo/Reuters
Wednesday, January 22, 2014 - 8:37am
tags:
Torrent Pharmaceuticals
Drug Approvals Take Customized Approach Based on Disease
Bloomberg
Wednesday, January 22, 2014 - 8:36am
tags:
drug approvals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.